Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
作者信息
Hasan Ali Omar, Bomze David, Risch Lorenz, Brugger Silvio D, Paprotny Matthias, Weber Myriam, Thiel Sarah, Kern Lukas, Albrich Werner C, Kohler Philipp, Kahlert Christian R, Vernazza Pietro, Bühler Philipp K, Schüpbach Reto A, Gómez-Mejia Alejandro, Popa Alexandra M, Bergthaler Andreas, Penninger Josef M, Flatz Lukas
机构信息
Department of Medical Genetics, Life Sciences Institute, University of British Columbia, Vancouver, Canada.
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
出版信息
Clin Infect Dis. 2021 Nov 2;73(9):1746. doi: 10.1093/cid/ciab532.
Abstract
摘要
相似文献
1
Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Clin Infect Dis. 2021 Nov 2;73(9):1746. doi: 10.1093/cid/ciab532.
2
Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
Clin Infect Dis. 2021 Nov 2;73(9):e2869-e2874. doi: 10.1093/cid/ciaa1496.
3
Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
Clin Exp Immunol. 2020 Nov;202(2):210-219. doi: 10.1111/cei.13500. Epub 2020 Aug 7.
4
Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays.
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.02890-20.
5
Beta-2-Glycoprotein-I Deficiency Could Precipitate an Antiphospholipid Syndrome-like Prothrombotic Situation in Patients With Coronavirus Disease 2019.
ACR Open Rheumatol. 2021 Apr;3(4):267-276. doi: 10.1002/acr2.11245. Epub 2021 Mar 19.
6
Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases.
Clin Exp Rheumatol. 2020 Jul-Aug;38(4):754-759. Epub 2020 Jul 28.
7
Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
Euro Surveill. 2021 Dec;26(48). doi: 10.2807/1560-7917.ES.2021.26.48.2001690.
8
IgA antiphospholipid antibodies are an independent risk factor for thromboses.
Lupus. 2008 Nov;17(11):996-1003. doi: 10.1177/0961203308093460.
9
Antiphospholipid antibodies in young women with and without oral contraceptive use.
Blood Coagul Fibrinolysis. 2003 Jan;14(1):57-60. doi: 10.1097/00001721-200301000-00010.
10
IgA Antiphospholipid Antibodies and Anti-Domain 1 of Beta 2 Glycoprotein 1 Antibodies are Associated with Livedo Reticularis and Heart Valve Disease in Antiphospholipid Syndrome.
Adv Clin Exp Med. 2014 Sep-Oct;23(5):729-33. doi: 10.17219/acem/27570.
引用本文的文献
1
Longitudinal serologic and viral testing post-SARS-CoV-2 infection and post-receipt of mRNA COVID-19 vaccine in a nursing home cohort-Georgia, October 2020‒April 2021.
PLoS One. 2022 Oct 27;17(10):e0275718. doi: 10.1371/journal.pone.0275718. eCollection 2022.
2
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION).
Lupus. 2021 Dec;30(14):2276-2285. doi: 10.1177/09612033211062523. Epub 2021 Dec 16.
3
Comparison of Serum Total IgA Levels in Severe and Mild COVID-19 Patients and Control Group.
J Clin Immunol. 2022 Jan;42(1):10-18. doi: 10.1007/s10875-021-01149-6. Epub 2021 Oct 25.
Zotero 插件